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Abstract
Hypercholesterolemia, a risk factor for cardiovascular and cerebrovascular diseases, is
a silent health problem. It occurs due to buildup of large amount of cholesterol in blood
vessels resulting in narrowed blood vessels or blockage of the flow of blood and causes
cellular dysfunction. The predisposing factors for hypercholesterolemia are carbohy‐
drates‐enriched diet, unhealthy fats, and red meat. Moreover, family history, obesity,
hypokinetic lifestyle, aging, and oxidative stress are associated with hypercholestero‐
lemia.  Therapeutic  interventions  of  hypercholesterolemia  involve  cessation  of  bad
habits,  regular  exercise,  consumption  of  cholesterol  buster  diets,  and  cholesterol‐
lowering drugs.  However,  cholesterol‐lowering drugs have low efficacy,  and some
patients cannot tolerate the adverse effects of hypocholesterolemic drugs. In light of this,
there has been great interest to address natural cholesterol busters as first choice as
cholesterol‐lowering option.  Healthy diet,  regular  exercise and natural  cholesterol‐
lowering agents are documented to decrease blood cholesterol level. Natural cholesterol
busters include dietary fibers, plant sterols, healthy fats, smart proteins, antinutrients,
antioxidants, and L‐arginine. These busters not only decrease cholesterol oxidation and
absorption but  also increase cholesterol  catabolism and elimination.  Most  of  these
busters are found in cereals, oatmeal, fruits, vegetables, legumes, and fermented foods.
The natural cholesterol busters are recommended strategies for treatment of hypercho‐
lesterolemia alone or in combination with cholesterol‐lowering drugs.
Keywords: hypercholesterolemia, health diet, antioxidants, antinutrients, cardiovas‐
cular diseases, L‐arginine
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1. Introduction
Cholesterol is an important component in cell membrane that maintains the structure and
function of the cells. Moreover, cholesterol is a precursor of sex hormones, corticosteroid, and
vitamin D.  This  vitamin is  involved in bone formation,  modulates immune system, and
regulates gene expression [1].  Cholesterol can be catabolized into bile acids that play an
important role in digestion and absorption of fat diets and fat‐soluble vitamins. The cells get
its cholesterol through two pathways, endogenous source by means of biosynthesis in liver
(80 %) and exogenous source from the diet (20%) [2]. Cholesterol is transported throughout
the bloodstream by joining to specific proteins and lipids forming lipoproteins. There are four
main types of lipoprotein acting as cholesterol carriers in circulation: chylomicrons, very low‐
density lipoproteins (VLDL),  low‐density lipoprotein (LDL) “bad cholesterol”,  and high‐
density lipoprotein (HDL) “good cholesterol” [1].
HDL elicits cardioprotective function by reverse cholesterol transport to the liver to be
catabolized, moreover, HDL has antioxidant and anti‐inflammatory effects as well as involved
in nitric oxide (NO) homeostasis [3]. Under hypercholesterolemic conditions, HDL can be
turned into a foe for vascular endothelium through production of free radicals that induced
vascular cells and erythrocytes damage [3]. Moreover, cholesterol enrichment decreases
membrane fluidity, disrupts cell signaling, induces toxic oxysterols, modulates gene expres‐
sion, and induces apoptosis [4]. This results in disruption of redox balance and NO homeo‐
stasis, particularly in vascular cells and erythrocytes. Cholesterol‐enriched erythrocyte
membrane causes a reduction in the deformability of cells and impairment of the hemorheo‐
logical behavior that can initiate cardiovascular disease [5]. Oxidative stress is one of the
proposed mechanisms responsible for the changes in erythrocytes under hypercholesterolemic
conditions; hence, erythrocytes lose their antioxidant power and become oxidized erythro‐
cytes, which triggers foam cell formation by a mechanism similar to oxidized lipoproteins [5].
Therefore, oxidized erythrocytes are addressed as a new culprit in vascular diseases. Figure 1
displays the double face of cholesterol.
Figure 1. Beneficial and detrimental effects of cholesterol. Asterisk indicates hypercholesterolemic conditions.
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Cholesterol‐lowering drug therapies particularly with cholesterol biosynthesis inhibitors are
associated with adverse effects such as myopathies, neuropathies, liver dysfunction, weakness,
and depression [6]. However, intake of natural cholesterol busters reduces blood cholesterol
level with minimal side effects [7–9]. Natural cholesterol busters include healthy diet—
drinking excess cold water and avoidance of stress with regular exercise. Moreover, many
nutraceuticals have cholesterol‐lowering action; they include dietary fibers, plant sterols,
healthy fats, smart proteins, antinutrients, antioxidants, and L‐arginine [10]. These busters act
by modulation biochemical pathways such as appetite suppression, inhibition of digestion,
and absorption of dietary fats. In addition, they not only increase the metabolic rate and
lipolysis but also decrease lipogenesis and inhibit adipocyte differentiation. Figure 2 shows
the possible mechanisms by which natural cholesterol‐lowering agents decrease plasma
cholesterol levels.
Figure 2. Beneficial effects of natural cholesterol busters.
On this basis, the selection of natural cholesterol‐lowering agents with dual action such as lipid
lowering and antioxidant activities with minimal side effects is very essential. Natural
cholesterol busters can reduce blood cholesterol levels and risk of vascular diseases without
adverse effects. This chapter highlights natural cholesterol busters as first line of cholesterol‐
lowering strategy.
2. Natural cholesterol busters
The first choice to decrease the blood cholesterol levels is lifestyle change including healthy
diet—drinking excess of water, avoidance of stress and regular exercise. Moreover, there are
a group of nutraceuticals that can be considered as cholesterol busters. Some of these nutra‐
ceuticals are plant sterols, healthy fats, dietary fibers, antinutrients, antioxidants, and L‐
arginine.
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2.1. Healthy lifestyle as natural cholesterol busters
2.1.1. Health diet and exercise
Diet and lifestyle are major causes of dyslipidemia, diabetes, and cardiovascular diseases.
Particularly, protein‐enriched diet produces satiating effect and helps stave off hunger [10].
Consumption of plant‐based foods lowers the rate of many chronic diseases; this is attributable
to diets which contain smart proteins, trace elements, foliate, antioxidants, and antinutrients
[10]. Additionally, low carbohydrate consumption modulates hormones release, increases
lipolysis, and enhances fatty acids oxidation [10]. On the other hand, aerobic exercise decreases
lipogenesis and activates lipoprotein lipase that increases lipolysis, resulted in enhancement
of fat clearance and burning [11].
In these situations, depot fats and free fatty acids were utilized as fuel sources for muscle work
[12]. Therefore, health diet with regular exercise (3h/week) at least for 5 days per week
decreases subcutaneous fats, visceral fats as well as improve blood lipid levels [12]. Generally,
the reduction of body fats is associated with a decrease of total cholesterol, triacylglycerol,
LDL, while HDL levels were increased [10]. Furthermore, health diet and lifestyle modifica‐
tions improve the availability of nitric oxide [10]. Therefore, healthy diets enriched with plant
protein, low in carbohydrate and fat, devoid of trans fats (margarine, snack food, packaged
baked food, and fried fast food), with regular exercise could be considered the best choice to
treat hypercholesterolemia. Besides the aforementioned effects, caloric restrictions with
exercise preserve antioxidant capacity as well as reduce reactive oxygen species formation and
reduce apoptosis.
2.1.2. Cessation of bad habits
Cigarette smoking and alcohol drinking are most common bad habits worldwide. Combined
use of both smoking and alcohol is more damaging to health than use of either alone. The most
serious medical consequences of smoking and alcohol are vascular diseases and cancer [13].
This attribute of cigarette smoking enhances catecholamine release and inhibits lipoprotein
lipase activity; this results in an increase in levels of chylomicrons, VLDL, and LDL with a
decrease in HDL levels [14]. These resulted in alteration of lipid profile associated with decline
of antioxidant power with an increase of lipid peroxidation, thrombosis, and vascular dys‐
function [13]. Smoking cessation averts these deleterious effects on lipid abnormality, partic‐
ularly HDL levels [14].
The liver plays a central role in the regulation of cholesterol homeostasis. Alcohol drinking
causes fatty liver, besides this alcohol is metabolized into acetaldehyde and reactive oxygen
radicals [15]. Acetaldehyde and reactive oxygen radicals can interact with proteins, lipids, and
other biomolecules in the cell, resulting in adduct formation which is harmful to the liver.
Moreover, acetaldehyde‐protein adducts upregulate lipogenetic genes in the liver [15]. Several
studies confirmed that chronic alcoholism induced abnormality in lipid metabolism with
elevation of triacylglycerol and cholesterol‐enriched lipoproteins in the blood [16].
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2.2. Nutraceutical as natural cholesterol busters
2.2.1. Healthy fats
Dietary fatty acids are considered one of the main important dietary supplements that strongly
determine the development of cardiovascular diseases. The dietary fatty acids include
saturated fatty acids, monounsaturated fatty acids, and polyunsaturated fatty acids (PUFAs)
[17]. Saturated fatty acid–rich diets are implicated in the promotion of cardiovascular diseases,
while monounsaturated fatty acids and PUFAs have cardioprotective effects [17]. In particular,
PUFAs are essential dietary elements for human body because human body lacks desaturating
enzymes that are required for PUFAs’ biosynthesis [18].
PUFAs are classified according to the position of first double bond from the methyl end (omega
carbon) into omega‐3 (ω3) PUFAs and omega‐6 (ω6) PUFAs. Dietary intake of ω3‐PUFAs with
reduction in ω6‐PUFAs consumption is beneficial for cardiac health [19], while higher
consumption of ω6‐PUFAs with lower ω3‐PUFAs dietary contents is a risk for many diseases,
particularly cardiovascular diseases. Inside the human body α‐linolenic acid can be converted
to eicosapentaenoic acid and docosahexaenoic acid by desaturase and elongase enzymes in a
series of biochemical reactions [20]. The process of endogenous desaturation and elongation
of α‐linolenic acid into eicosapentaenoic acid and docosahexaenoic acid is usually inefficient.
Therefore, intake of α‐linolenic acid is essential for production of eicosapentaenoic and
docosahexaenoic acids [21–24].
Omega‐3 fatty acids are the precursors of biologically active mediators with health benefits
with regard to their anti‐inflammatory, antithrombotic, hypolipidemic, and cardioprotective
effects [20]. However, ω6‐PUFA produces pro‐inflammatory, pro‐thrombotic, and pro‐
atherogenic mediators [21–24]. Therefore, balanced ratio between ω3‐PUFAs/ω6‐PUFAs
dietary intake is recommended for the decrease of cardiovascular risk. The reversal of this ratio
has been considered responsible for the high prevalence of cardiovascular disease [21–24].
The ω3‐PUFAs are involved in the formation of phospholipids that are involved in reverse
cholesterol transport to the liver for catabolism [24]. Additionally, intake of ω3‐PUFAs can
reduce triacylglycerol levels through inhibition of hepatic lipogenesis and very low‐density
lipoproteins production by the liver and output into circulation. The ω3‐PUFAs have been
shown to increase plasma LDL with large particle size, which is much less atherogenic than
LDL that cannot infiltrate blood vessels of vascular endothelium to start development of
atherosclerosis [24]. Moreover, ω3‐PUFAs downregulate sterol regulatory element‐binding
protein, resulting in suppression of gene expression of 3‐hydroxy‐3‐methyl‐glutaryl CoA
reductase, a rate‐limiting enzyme in cholesterol synthesis [25]. ω3‐PUFAs also activate liver X
receptors that upregulate expression of 7‐α‐hydroxylase, the main enzyme in conversion of
cholesterol into bile acids [26].
Diet enriched with ω3‐PUFAs is abundant in plant and marine sources, such as flaxseed,
canola, salmon, mackerel, herring, and tuna. The fish oil is composed of higher percent of ω3‐
PUFAs; therefore, they are the best source of biologically active ω3‐PUFAs mediators. The ω3‐
PUFAs have susceptibility to oxidative damage; therefore, antioxidants supplementation is
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recommended during ω3‐PUFAs consumption. The ω3‐PUFAs are promising therapeutic
options for the prevention and treatment of hypercholesterolemia. The risk of antioxidants
deficiency and mercury contamination during intake of fish oils must be considered.
2.2.2. Phytosterols
Phytosterols are plant source sterols; they are similar to animal sterol in the presence of steroid
nucleus, whereas they differ in their side chain. Phytosterols have been incorporated in many
dietary regimens to reduce plasma cholesterol levels and provide a cardioprotective action
[27–28]. Phytosterols are classified according to their saturation into sterols and stanols;
saturation of sterols produces stanols. The main physterols are sitosterol and campesterol, with
their respective stanols, sitostanol and campestanol [27–28]. Phytosterols are relatively less
absorbed than cholesterol, particularly stanols. Addition of phytosterols to the diet of hyper‐
cholesterolemic patients can effectively reduce blood cholesterol levels [29–30]. Phytostanols
are preferred than sterols because the effect of sterols diminishes over time, while stanols’
effect persists for a long time. Maximal reduction in cholesterol was reported with daily intake
of 2.0 g of plant stanols. The effect of phytosterols is food dependent because the maximal bile
secretion is with or directly after meals where stanols can target micelle formation to reduce
the absorption of cholesterol and lipids [31–35]. Phytostanols esters showed greater effective‐
ness if taken on daily basis in sufficient amounts (0.8–2.0 g) with meals [31–35]. The beneficial
effect of stanols over LDL reduction appears after 1–2 weeks of (2.0 g) daily consumption. Most
importantly, this reduction in LDL persists as long as stanols being consumed [31–35].
Several mechanisms including interference with intestinal cholesterol solubility, inhibition of
digestive enzymes, and decreasing cellular uptake of cholesterol have been proposed to
explain the cholesterol‐lowering effects of phytosterols [31–35]. Therefore, phytosterols reduce
the absorption of both dietary and biliary cholesterol from the intestinal tract. Moreover,
phytosterols induce the expression of ATP‐binding cassette transporters, thus increasing the
efflux of cholesterol from the intestinal cells [31–35]. In addition, phytosterols suppress the
activity of acyl‐cholesterol acyl transferase required for sterols absorption, consequently
reducing intestinal cholesterol uptake. Phytosterols are partially inhibiting dietary and biliary
cholesterol absorption by 30–50% through inhibition of cholesterol emulsification through
disruption of the lipid micelles, reducing its solubility and availability for intestinal absorp‐
tion [31–35]. Phytosterols are present naturally in many plants, such as corn, soybeans, and
sunflower seeds. The risk of beta‐sitosterolemia must be considered during intake of phytos‐
terols as cholesterol‐lowering therapy.
2.2.3. Dietary fibers
Dietary fibers including cellulose and its derivatives as well as lignin are considered as non‐
digestible parts of food. Diet rich in fiber has been reported to have an inverse relationship to
cardiovascular risk. Therefore, fiber‐enriched diets are recommended by many leading
organizations to improve human health [36–37]. The chemical composition of dietary fibers is
carbohydrate in nature; they are present in edible plants. Dietary fibers resist alimentary
digestive enzymes, are non‐absorbable and susceptible for partial fermentation by normal
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flora gastrointestinal tract [36–37]. Generally, dietary fibers are classified according to their
solubility into soluble and insoluble fibers. Inulin, oligofructosides, pectin, mucilage, psyllium,
gum, polysaccharides, and β‐glucans are examples for soluble fibers, whereas lignin, cellulose,
hemicellulose, and resistant starch are examples for insoluble fibers [38–41]. Chitosan can
reduce the risk of cardiovascular diseases because it can lower triacylglycerol and cholesterol
levels by increasing bile acid excretion [42].
Dietary fibers have hypolipidemic effect over both triacylglycerol and cholesterol‐enriched
lipoproteins [41]. The biochemical mechanisms underlying the hypolipidemic effect of dietary
fibers may be due to different hypotheses. Dietary fibers form complexes with dietary fats,
cholesterol, and bile acids. Therefore, fat digestion by pancreatic lipases is inhibited, while
hepatic bile synthesis and cholesterol excretion are enhanced [41, 43]. In addition, dietary fibers
can entrap water and water‐soluble foodstuff, such as glucose, resulting in reduction in glucose
absorption. Therefore, post‐prandial plasma insulin declines with suppression of its stimulat‐
ing action for 3‐hydroxy‐3‐methylglutaryl‐CoA reductase in cholesterol synthesis. This
resulted in decrease of cholesterol biosynthesis with decrease in blood cholesterol levels [41,
43]. Fermentation of fibers by intestinal flora produces short chain fatty acids such as propionic
and butyric acids. These acids can suppress hepatic cholesterol synthesis via competitive
inhibition of 3‐hydroxy‐3‐methyl‐glutaryl CoA reductase and downregulate most of lipogenic
enzymes [41, 43–45].
Dietary fibers promote growth of intestinal microflora such as Lactobacillus acidophilus [37].
Therefore, dietary fibers that selectively stimulate the growth and activity of beneficial
microflora are known as “prebiotics”; “probiotics” in the gastrointestinal tract improve the
intestinal microbial balance, thus improving human health. When probiotics and prebiotics
are used in combination, they are known as “synbiotics” [46]. The use of synbiotics is to
improve gut health and exert other health‐promoting effects, such as modulation of the
immune system, antihypertensive effects, prevention of cancer, antioxidant effects, reduction
of dermatitis symptoms, facilitation of mineral absorption, and improvement of candidiasis
[46]. Additionally, synbiotics has cholesterol‐lowering properties through deconjugation of
bile acids by bile‐salt hydrolase, thus leading to coprecipitation of cholesterol with deconju‐
gated bile [46]. Other explanations for cholesterol‐lowering effects of probiotics include
utilization of cholesterol in the cell membranes during growth of probiotics, conversion of
cholesterol into coprostanol and production of short‐chain fatty acids upon prebiotics fermen‐
tation by probiotics [46].
Dietary fibers are present in nuts, beans, lentil, lupin, blueberries, cucumber, green leafy
vegetables, green beans, carrot, celery, yoghurt, and fermented foods.
2.2.4. Antioxidants
Antioxidants can minimize cellular damage by inactivating free radicals, which could attack
other cellular molecules. Enzymatic antioxidants that could provide a protection against free
radicals are superoxide dismutase, catalase, and glutathione peroxidases [47]. Non‐enzymatic
antioxidants with similar function are present widely in the biological system and able to
quench many types of free radicals. They include glutathione, vitamin E, vitamin C, β‐carotene,
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retinols, selenium, copper, zinc, manganese, and others [47]. Hypercholesterolemia upregu‐
lates the activity of free radical–generating enzymes; however, it downregulates the activity
of antioxidant enzymes that trigger the production of reactive oxygen metabolites [48]. These
reactive metabolites provoke lipoproteins oxidation, protein glycation, and glucose auto‐
oxidation. Therefore, hypercholesterolemia has been implicated as pathogenesis of pancrea‐
titis, hepatitis, renal injury, stroke, atherosclerosis, and metabolic syndrome by oxidative
damage‐dependent mechanism [49].
There are scientific evidences of the protective effects of naturally occurring antioxidants in
biological systems. Consequently, the identification of natural antioxidants with cholesterol‐
lowering effect in diet consumed by human is very important. Antioxidants are attractive
alternative therapy to treat hypercholesterolemic patients [50]. The antioxidants with choles‐
terol‐lowering capability include antioxidant vitamins, coenzymeQ‐10, resveratrol, grape
seed, cherry seed, and spices. Moreover, flavonoids, such as silymarin, rutin, quercetin,
naringin, and hesperidin, were used for the same purpose [7–9]. Chrysin is a natural flavonoid
that is able to decrease plasma lipid concentration and has an antioxidant property [51].
Moreover, rice bran oil is involved in lipid metabolism and oxidation; therefore, it has
significant health benefits by the modulation of lipid profiles and preservation of normal redox
balance in hypercholesterolemic conditions [52]. Antioxidants are exerting their beneficial
effects as free radical scavengers and as chelators of pro‐oxidant metals. Furthermore,
administration of antioxidants augments endogenous antioxidant power as well as inhibits
free radicals generating enzymes [54]. Antioxidants inhibit the oxidation of lipoproteins,
protect the oxidative damage of erythrocytes and preserve the availability of nitric oxide in the
body [53]. Consequently, antioxidants prevent hypercholesterolemia‐induced vascular cells
damage. Vegetables and fruits are good source of antioxidants; they include reddish, lettuce,
carrot, tomato, cucumber, red cabbage, and low caloric fruits such as apple, grape fruits and
orange.
2.2.5. Antinutrients
Antinutrients are plant secondary metabolites such as saponins, flavonoids, alkaloids, tannins,
oxalates, phytates, protease inhibitors, amylase inhibitors, lipase inhibitors, and lectins. They
are secreted by the plant as a part of the defense mechanism [54, 55]. Human beings use these
agents for many beneficial purposes. Some of the antinutrients are used in modulation of
gastrointestinal function. Lectins have high binding capacity to the intestinal brush border
membrane. This stimulates the release of anorectic neuropeptides that produce satiety and
decrease food intake [55]. However, lectins can cause severe intestinal damage with disrupting
digestion provoking food allergies and other immune responses [55]. Saponins are amphi‐
pathic antinutrients which can reduce cholesterol absorption by disruption of cholesterol
micelle formation and downregulate the activity of lipogenic enzymes [54, 55]. Furthermore,
saponins also reduce the uptake of glucose from the gut through intraluminal physicochemical
interaction [54, 55].
Tannins are present in most cereals and are able to inhibit the activities of protease, amylase
and lipase [54–56]. Chlorogenic acid is a member of antinutrients present in green coffee.
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Soybeans, fenugreek, bean, and ginseng are good sources of antinutrients. Antinutrients have
immune‐potentiating action, anticancer effect, and antioxidant power, which could prevent
cardiovascular diseases. However, the risk of hemolysis, pancreatic hypertrophy, minerals
deficiency, vitamins deficiency, and other malabsorption syndrome must be considered during
intake of antinutrients for treatment of hypercholesterolemia [54–56]. Table 1 annotated the
common dietary sources, the main mechanisms of action, and the probable side effects of
natural cholesterol lowering agents.
Cholesterol
buster 
Dietary source  Main mechanism
of action 
Probable
side effects
Healthy fats Salmon, flaxseed,
and canola
oils
Decrease cholesterol
synthesis and
increase its catabolism
Depletion of
antioxidant
Phytosterols Corn, soybeans,
and sunflower
seeds
Induce expression of
ATP‐binding
cassette transporters
Beta‐Sitosterolemia
Dietary fibers Legumes, beans,
and vegetables
Form complexes with
dietary cholesterol
and bile acids
Abdominal discomfort
Antinutrients Beans, fenugreek,
and ginseng
Produce satiety
and decrease
cholesterol micelles
formation
Hemolysis and
malabsorption
syndrome
Antioxidants Fruits, vegetables,
and rice
bran oil
Decrease free radicals
formation
and lipoprotein
oxidation
‐
L‐arginine Poultry,
seafood,
and lupine
Antioxidants and
restores
nitric oxide
bioavailability
Hypotension
Table 1. The common dietary sources, the main mechanisms of action, and the probable side effects of natural
cholesterol busters.
2.2.6. L‐Arginine
Nitric oxide is an important vasodilator and has many biological functions. Several cells
including endothelial cells and erythrocytes can produce nitric oxide which uses L‐arginine
as a substrate and tetrahydrobiopterin and flavoproteins as cofactors [57, 58]. Hypercholes‐
terolemia is associated with the increased oxidative stress that reduces the nitric oxide
bioavailability through disruption of L‐arginine transport into cells, inactivation of nitric oxide
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synthase, and activation of arginase [9, 58, 59]. Furthermore, high blood cholesterol levels
increase endogenous L‐arginine analogues that are able to inhibit nitric oxide synthesis. In
particular, asymmetric dimethylarginine competes with L‐arginine at the catalytic site of nitric
oxide synthase, and symmetric dimethylarginine blocks the transport of L‐arginine into the
cells via the transporter for cationic amino acids [9, 58, 59]. In hypercholesterolemia, erythro‐
cytes and endothelial cells float in cholesterol‐enriched media. This results in a decrease of
nitric oxide production and endothelial dysfunction [9, 58, 59]. On the contrary, L‐arginine
supplementation restores nitric oxide levels and reduces vascular oxidative damage in
hypercholesterolemic conditions [57]. It has been reported that L‐arginine–enriched foods
lower LDL levels; this indicates positive health benefits associated with L‐arginine on cardio‐
vascular system [60]. Moreover, dietary supplementation with L‐arginine stimulates nitric
oxide biosynthetic pathway. In addition, polyphenolic compound mediates L‐arginine
transport into cells and enhances nitric oxide production [60, 61]. L‐arginine–enriched foods
include dairy products, poultry, seafood, wheat germ, lupine, granola, oatmeal, peanuts, nuts,
pumpkin seed, and chickpeas. The risk of hypotension must be considered during intake of
L‐arginine as a cholesterol‐lowering agent. Figure 3 shows role of cholesterol busters in
prevention hypercholesterolemia induced endothelial dysfunction.
Figure 3. Mechanisms of action of cholesterol busters in prevention hypercholesterolemia induced endothelial dys‐
function. Green color indicates the site of action of therapeutic agent.
Cholesterol Lowering Therapies and Drugs10
3. Suggestion and recommendations
Based on the current data in this chapter, the following recommendations aid in maintaining
a healthy life.
• Eat three to five healthy diet daily containing different foods. Healthy diets contain fruits,
vegetables, and legumes with less fat and carbohydrate.
• Reduce the intake of salt, flour, and sugar; use more fibers and reduce the amount of food
in your plate.
• Consume cold water and sugar‐free gum during a feeling of false or emotional hunger.
• Motivate regularly such as walking, riding a bike, and other activities (30–45 min), at least
5 days weekly to burn off the excess calories.
• Prohibit bad habits such smoking and alcohol drinking as conceivable.
• Avoid overcrowding, noise, and contaminant exposure as possible.
• Check your body weight weekly.
• Examine your blood sugar level and plasma lipids profile for every 6 months.
4. Summary
Healthy diet and exercise can successfully manage blood cholesterol levels, besides supple‐
mentation of natural cholesterol busters. Natural cholesterol busters not only decrease
cholesterol absorption, but also increase cholesterol metabolism and elimination. The inter‐
vention of natural cholesterol busters is the safest strategy in the prevention and treatment of
hypercholesterolemia. The hypocholesterolemic properties of natural cholesterol busters have
been proved; however, further studies are required to address general recommendations
considering human variability in response to dietary regimen. The natural cholesterol busters
are found in cereals, oatmeal, fruits, vegetables, and legumes. In case of failure of natural
cholesterol busters as first choice cholesterol‐lowering option, the cholesterol‐lowering drugs
are recommended with natural cholesterol busters. Take care that high intake of antinutrients
may be associated with serious health problems due to the presence of phytate, oxalate,
cyanogenic glycoside, and other toxic antinutrients.
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